Aminocaproic Acid
NDC 16571-327, Aminocaproic Acid, tablet, from RISING PHARMA HOLDINGS, INC..
- Product NDC
- 16571-327
- Status
- Listed
- Labeler
- RISING PHARMA HOLDINGS, INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213944
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMINOCAPROIC ACID1000 mg/1
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-327-03 | 16571032703 | 30 TABLET in 1 BOTTLE (16571-327-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/ae768406-955e-4863-9549-6c43662e5295
Use it
Look up 16571-327 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-327. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.